Trinity Biotech plc (TRIB)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
13.05+0.02 (+0.15%)
At close: 4:00 PM EDT
People also watch:
OSURQDELVIVORGENTGEN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open13.00
Prev Close13.03
Bid9.92 x 100
Ask15.20 x 200
Day's Range12.86 - 13.05
52wk Range9.20 - 15.74
1y Target EstN/A
Market Cap300.36M
P/E Ratio (ttm)55.53
Beta1.04
Volume65,238
Avg Vol (3m)52,895
Dividend & Yield0.00 (0.00%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Barrons.com4 days ago

    [$$] Trinity Biotech: Stock Has More Than 50% Upside

    After a few tough years, prospects for Trinity Biotech are finally looking up. In July, Trinity (TRIB), a maker of medical instruments and tests for diseases like HIV and diabetes, reported a return to revenue growth for the first time in over a year. Perhaps more notably, its Meritas Troponin point-of-care test, used to detect the presence of heart attacks in emergency room patients, and long the focus of investor attention, appears to be inching closer to Food and Drug Administration approval.

  • Zacks23 days ago

    Trinity Biotech (TRIB) Enters Overbought Territory

    Trinity Biotech plc (TRIB) has moved higher as of late, but there could definitely be trouble on the horizon for this company

  • Trinity Biotech Plc: Strong price momentum but will it sustain?
    Capital Cubelast month

    Trinity Biotech Plc: Strong price momentum but will it sustain?

    Trinity Biotech Plc relative valuation is UNDERVALUED and it has a fundamental analysis score of 59.Our analysis is based on comparing Trinity Biotech Plc with the following peers – OraSure Technologies, Inc., Bio-Rad Laboratories, Inc. Class A, Alere Inc., Quidel Corporation, Chembio Diagnostics, Inc., Abbott Laboratories, Danaher Corporation, Thermo Fisher Scientific Inc. and Vermillion, Inc. […] (Read more...) The post Trinity Biotech Plc: Strong price momentum but will it sustain? appeared first on CapitalCube.